3 results
To evaluate whether the efficacy in terms of progression free survival (PFS) of second-line tepotinib in combination with gefitinib is superior to pemetrexed+cisplatin/carboplatin in subjects with T790M negative, MET+ locally advanced or metastatic…
The main objective of this study is to determine whether use of the PReDicT Test to direct antidepressant treatmentresults in an increased proportion of depressed patients showing a response to treatment at week 8 compared toTreatment as Usual (TaU…
The study will be performed in 2 parts, Part 1 and Part 2. Part 2 has been clinically completed. The remainder of this document concerns Part 1 only. The purpose of Part 1 of this study is to determine the reversal of the blood thinning effects of…